| Sanofi-Aventis (Suisse) SA - Xatral uno, comprimés retard | | 55188 | | 01 | | Xatral uno | | comprimés retard | | G04CA01 | | Alfuzosin | | 17.12.1999 | | |
| | Composition | | alfuzosini hydrochloridum 10 mg, hypromellosum, ricini oleum hydrogenatum, ethylcellulosum, silica colloidalis hydrica, magnesii stearas, mannitolum, povidonum, cellulosum microcristallinum, ethanolum 96 per centum, aqua purificata, E 172 (flavum), pro compresso. | | Packungsbestandteile | | Comprimés retards | | | | | Principe actif | Concentr. |
|---|
| Alfuzosine Hydrochloride | 10 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Alfuzosine Hydrochloride | 10 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Aqua Purificata | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Ethanol | 96 | | | Ethylcellulosum | | | | Hypromellosum | | | | Magnesii Stearas | | | | Mannitol | | | | Per Centum | | | | Povidone | | | | Pro Compresso | | | | Ricini Oleum Hydrogenatum | | | | Silica Colloidalis Hydrica | | |
| |
| |
|
